节点文献
拉莫三嗪治疗顽固性癫痫的临床观察
Clinical efficacy of lamotrigine in patients with refractory epilepsy
【摘要】 对30例顽固性癫痫病人进行拉莫三嗪开放添加治疗。为期三个月。以后仍服用,剂量100~400mg/d,(平均226.5±92.4)。30例患者总的癫痫发作次数减少46%,13%完全控制。拉莫三嗪对控制各类癫痫发作均有效,总显效率达67%,不良反应较少,主要是变态反应性皮疹,停药后消失,实验室检查完全正常
【Abstract】 Thirty refractory epileptic patients who entered on a open add on trial. The treatment period was 3 to 17 months. These patients were taking a daily Lamotrigine (LTG) dosage of 100 400 mg(mean 225.6±92.44). The percentage of reduction of seizure frequency as compared with the pre LTG period(3 mouths of baseline) was 62%, seizure free 13%. LTG appeared to be effective over a broad range of different seizure types . The most importment adverse event reported by our patients was allergic skin rashes, which were generally mild and disappeared when the treatment was discontinued. Laboratory parameters showed normal.
- 【文献出处】 卒中与神经疾病 ,SRTOKE AND NERVOUS DISEASES , 编辑部邮箱 ,1997年02期
- 【分类号】R743.32
- 【被引频次】1
- 【下载频次】22